D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Liberty Media Series C
FWONK
|
+$430M |
| 2 |
Alibaba
BABA
|
+$364M |
| 3 |
HP
HPQ
|
+$298M |
| 4 |
Pfizer
PFE
|
+$258M |
| 5 |
Booking.com
BKNG
|
+$244M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FRX
FOREST LABORATORIES INC
FRX
|
+$602M |
| 2 |
Liberty Media Series A
FWONA
|
+$321M |
| 3 |
AbbVie
ABBV
|
+$312M |
| 4 |
GE Aerospace
GE
|
+$233M |
| 5 |
SNDK
SANDISK CORP
SNDK
|
+$183M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.89% |
| 2 | Consumer Discretionary | 8.28% |
| 3 | Energy | 7.75% |
| 4 | Healthcare | 6.77% |
| 5 | Communication Services | 6.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
726
PUT
Alaska Air
ALK
$5.3B
| $18.8M | 0.02% |
431,800
| – | – |
|
727
Edwards Lifesciences
EW
$47.8B
| $18.7M | 0.02% |
1,098,786
+836,244
| +319% | +$13.2M |
|
728
CALL
PepsiCo
PEP
$191B
| $18.7M | 0.02% |
200,700
-50,800
| -20% | -$4.64M |
|
729
PUT
Travelers Companies
TRV
$81.4B
| $18.6M | 0.02% |
197,800
| – | – |
|
|
ALXN
730
CALL
DELISTED
Alexion Pharmaceuticals
ALXN
| $18.6M | 0.02% |
111,900
-1,600
| -1% | -$263K |
|
731
CALL
CME Group
CME
$92.3B
| $18.5M | 0.02% |
230,800
+12,600
| +6% | +$950K |
|
732
CALL
Medtronic
MDT
$108B
| $18.4M | 0.02% |
296,600
-12,100
| -4% | -$769K |
|
|
SCTY
733
PUT
DELISTED
SolarCity Corporation
SCTY
| $18.4M | 0.02% |
308,100
-83,300
| -21% | -$5.73M |
|
734
Oil States International
OIS
$512M
| $18.3M | 0.02% |
296,297
+244,837
| +476% | +$15.4M |
|
735
APA Corp
APA
$12.3B
| $18.3M | 0.02% |
194,961
+181,569
| +1,356% | +$18M |
|
|
MDRX
736
DELISTED
Veradigm Inc. Common Stock
MDRX
| $18.2M | 0.02% |
1,359,389
+386,386
| +40% | +$5.86M |
|
737
Bloomin' Brands
BLMN
$731M
| $18.2M | 0.02% |
990,599
+63,160
| +7% | +$1.16M |
|
738
Radian Group
RDN
$5.18B
| $18.2M | 0.02% |
1,273,556
-420,973
| -25% | -$5.89M |
|
739
PUT
Thermo Fisher Scientific
TMO
$208B
| $18.1M | 0.02% |
149,100
| – | – |
|
|
WPG
740
DELISTED
Washington Prime Group Inc.
WPG
| $18.1M | 0.02% |
115,190
+39,726
| +53% | +$6.73M |
|
741
BioMarin Pharmaceuticals
BMRN
$11.6B
| $18.1M | 0.02% |
251,107
+135,138
| +117% | +$8.88M |
|
742
PUT
Eastman Chemical
EMN
$7.74B
| $18.1M | 0.02% |
223,400
| – | – |
|
743
Bankunited
BKU
$3.36B
| $18.1M | 0.02% |
592,643
-24,803
| -4% | -$790K |
|
|
SFR
744
DELISTED
Starwood Waypoint Homes
SFR
| $18M | 0.02% |
691,988
-207,583
| -23% | -$5.53M |
|
745
Sunstone Hotel Investors
SHO
$2.2B
| $18M | 0.02% |
1,301,552
+548,402
| +73% | +$7.96M |
|
|
AMTD
746
PUT
DELISTED
TD Ameritrade Holding Corp
AMTD
| $18M | 0.02% |
539,000
| – | – |
|
|
PLL
747
DELISTED
PALL CORP
PLL
| $17.8M | 0.02% |
213,146
+109,979
| +107% | +$9.01M |
|
748
3M
MMM
$91.9B
| $17.8M | 0.02% |
+150,505
| New | +$18.1M |
|
749
CALL
Clorox
CLX
$11.8B
| $17.7M | 0.02% |
184,500
| – | – |
|
|
ADVS
750
DELISTED
Advent Software Inc
ADVS
| $17.6M | 0.02% |
559,041
+548,433
| +5,170% | +$17.6M |
|
Similar funds
D.E. Shaw & Co's Q3 2014 Portfolio in Review
As of Q3 2014, D.E. Shaw & Co held 4,729 positions worth $77.2B, up 5.1% from $73.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
D.E. Shaw & Co deployed $3.39B of net new capital in Q3 2014, opening 599 new positions and adding to 1,385 existing holdings. Its largest new stake was Liberty Media Series C: 16,804,239 shares worth $422M.
By sector, the portfolio is most concentrated in Technology at 8.9% of assets, up from 7.9% a quarter earlier, followed by Consumer Discretionary and Energy.
On the sell side, the largest reduction was Liberty Media Series A, an estimated $321M trimmed.
- D.E. Shaw & Co's largest Q3 2014 buy was Liberty Media Series C: 16,804,239 shares worth $422M.
- D.E. Shaw & Co added most to HP in Q3 2014, an estimated $298M increase.
- D.E. Shaw & Co's biggest Q3 2014 reduction was Liberty Media Series A, cutting an estimated $321M.
- D.E. Shaw & Co fully exited FOREST LABORATORIES INC in Q3 2014, selling an estimated $602M.
- D.E. Shaw & Co's ten largest holdings make up 12% of its $77.2B portfolio in Q3 2014.
- D.E. Shaw & Co opened 599 new positions and closed 674 in Q3 2014.
- D.E. Shaw & Co's portfolio value rose 5.1% quarter-over-quarter to $77.2B.
Based on D.E. Shaw & Co's 13F filing for Q3 2014, filed 14 Nov 2014.